Literature DB >> 25908873

Brain IL-6--Where Amylin and GLP-1 Antiobesity Signaling Congregate.

John-Olov Jansson1, Vilborg Palsdottir2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25908873     DOI： 10.2337/db14-1910

Source DB:  PubMed          Journal:  Diabetes        ISSN： 0012-1797            Impact factor:   9.461


× No keyword cloud information.
  4 in total

Review 1.  Neurometabolic Evidence Supporting the Hypothesis of Increased Incidence of Type 3 Diabetes Mellitus in the 21st Century.

Authors:  Anna Rorbach-Dolata; Agnieszka Piwowar
Journal:  Biomed Res Int       Date:  2019-07-21       Impact factor: 3.411

Review 2.  Mono and dual agonists of the amylin, calcitonin, and CGRP receptors and their potential in metabolic diseases.

Authors:  Nina Sonne; Morten A Karsdal; Kim Henriksen
Journal:  Mol Metab       Date:  2020-11-07       Impact factor: 7.422

3.  The dual amylin and calcitonin receptor agonist KBP-089 and the GLP-1 receptor agonist liraglutide act complimentarily on body weight reduction and metabolic profile.

Authors:  Anna Thorsø Larsen; Sofie Gydesen; Nina Sonne; Morten Asser Karsdal; Kim Henriksen
Journal:  BMC Endocr Disord       Date:  2021-01-07       Impact factor: 2.763

4.  Functional interleukin-6 receptor-α is located in tanycytes at the base of the third ventricle.

Authors:  F Anesten; C Santos; E Gidestrand; E Schéle; V Pálsdóttir; T Swedung-Wettervik; B Meister; K Patrycja Skibicka; J-O Jansson
Journal:  J Neuroendocrinol       Date:  2017-12       Impact factor: 3.627
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.